UK markets closed

Zomedica Pharmaceuticals Corp. (ZOM)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.1473+0.0033 (+2.29%)
As of 03:03PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,854
18,930
4,133
0
Cost of revenue
4,435
5,278
1,079
0
Gross profit
12,419
13,652
3,054
0
Operating expenses
Research development
2,466
2,578
1,673
8,044
Selling general and administrative
32,499
32,997
22,755
8,721
Total operating expenses
34,971
35,575
24,428
16,765
Operating income or loss
-22,552
-21,923
-21,374
-16,765
Interest expense
176
1
6
0.732
Total other income/expenses net
-79.62
-158
306
-178.933
Income before tax
-21,146
-19,381
-20,717
-16,912
Income tax expense
-3,650
-2,366
-2,333
0
Income from continuing operations
-17,496
-17,015
-18,384
-16,912
Net income
-17,496
-17,015
-18,384
-16,912
Net income available to common shareholders
-17,496
-17,015
-50,423
-16,912
Basic EPS
-0.02
-0.02
-0.05
-0.05
Diluted EPS
-0.02
-0.02
-0.05
-0.05
Basic average shares
979,924
979,924
956,534
364,445
Diluted average shares
979,924
979,924
956,534
364,445